Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/25/24 08:41 | 11/21/24 | IMNM | Health | Drug | Pharmaceutical Preparations | Siegall Clay B | WA | DO | P,CEO | 1 | P.m | 962 | 9.62 | 0 | 100 | 24 | 520 | D | ||||||||||||||
11/25/24 08:35 | 11/21/24 | IMNM | Health | Drug | Pharmaceutical Preparations | Lechleider Robert | WA | O | Chief Me | 1 | P | 150 | 9.48 | 0 | 16 | 16 | D | |||||||||||||||
11/25/24 08:33 | 11/21/24 | IMNM | Health | Drug | Pharmaceutical Preparations | Tsai Philip | WA | O | CTO | 1 | P | 198 | 9.43 | 0 | 21 | 21 | D | |||||||||||||||
9/20/24 19:26 | 9/19/24 | IMNM | Health | Drug | Pharmaceutical Preparations | Rosett Max | WA | O | CFO | 2 | M.d | 274 | 4.87 | 0 | 56 | 47 | D | |||||||||||||||
9/20/24 19:26 | 9/19/24 | IMNM | Health | Drug | Pharmaceutical Preparations | Rosett Max | WA | O | CFO | 2 | S.d | -274 | 4.87 | 0 | -56 | 47 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |